The involvement of the MEK5/ERK5 pathway in the origin of tumors of different lineages, such as lung adenocarcinoma and sarcoma, in MEK5DD transgenic mice demonstrates that constitutive activation of this pathway may promote oncogenesis in distinct tissues. The gene discussed is MAP2K5; the disease is lung adenocarcinoma.